The Drug Supply Chain Security Act (Act), Title II of the Drug Quality and Security Act, was recently signed into law and contains provisions related to the integrity of the drug distribution supply chain. State boards of pharmacy have received correspondence from attorneys indicating that the Act preempts states from recognizing or requiring NABP’s Verified-Accredited […]

Read More ›

NABP has launched the Verified Pharmacy Program™ (VPP™), which was developed in partnership with member boards of pharmacy to facilitate the sharing of information and to help provide for consistency among requirements related to nonresident pharmacy licensure. Effective as of July 1, 2013, the Virginia Board of Pharmacy has implemented new regulations regarding inspection requirements […]

Read More ›

The dangers of ordering medications online and of receiving illegal, potentially dangerous counterfeit products are highlighted in an investigative report by WFMY News in Cleveland, OH. Reporters ordered Lipitor® and Viagra®, two of the drugs most commonly purchased online, from three Web sites that they believed appeared to be legitimate pharmacy Web sites. After their […]

Read More ›

The National Association of Boards of Pharmacy® (NABP®) and the Accreditation Council for Pharmacy Education (ACPE) are pleased to announce that CPE Monitor® has reached a milestone with over five million continuing pharmacy education (CPE) activity records now stored in the CPE Monitor system. CPE Monitor is a national collaborative service from NABP, ACPE, and […]

Read More ›

The Tri-Regulator Leadership Collaborative met recently to review, discuss issues of mutual concern and set an agenda of work in the ongoing collaboration between the Federation of State Medical Boards (FSMB), National Association of Boards of Pharmacy (NABP), and National Council of State Boards of Nursing (NCSBN). A schedule of work agreed upon during this […]

Read More ›

The National Association of Boards of Pharmacy® (NABP®) recently amended the Model State Pharmacy Act and Model Rules of the National Association of Boards of Pharmacy (Model Act) in its effort to assist the boards of pharmacy as they work to protect the public health. The Model Act was revised to replace technology-specific language with […]

Read More ›

At the 2013 International Pharmaceutical Federation (FIP) World Congress hosted in Dublin, Ireland, NABP presented information on online pharmacy safety and rogue online drug sellers to delegates at a session dedicated to online health. NABP shared its finding with delegates that almost 97% of more than 10,000 Internet Web sites selling drug products and reviewed […]

Read More ›

At the request of several prescription monitoring program (PMP) administrators, NABP is working on building PMP software that will work seamlessly with NABP PMP InterConnect® as well as meet the needs of administrators, requestors, and data submitters with more options and flexibility. Five states – Idaho, Indiana, Kansas, Mississippi, and Nevada – have agreed to […]

Read More ›

Under a contract with the New Jersey Division of Consumer Affairs (Division) and the state’s Attorney General Jeffrey S. Chiesa, NABP will assist the Division with inspections of New Jersey pharmacies engaged in the practice of compounding. The planned pharmacy surveys will expand the Division’s already robust inspections of compounding pharmacies. As noted in a […]

Read More ›

Reaching a critical milestone in the generic Top-Level Domain (gTLD) approval process, the National Association of Boards of Pharmacy® (NABP®) application to own and operate the .PHARMACY domain suffix has passed the Internet Corporation for Assigned Names and Numbers (ICANN) initial evaluation. NABP intends to launch the .PHARMACY gTLD by the end of 2013, and […]

Read More ›